Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Minor: Basket Study of Entrectinib (RXDX-101) · Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) Trial completed
- Minor: Tirbanibulin for Pediatric Warts Trial completed
- Minor: ENV-101 · Lung Fibrosis (WHISTLE-PF Trial) Trial completed
- Minor: Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, · Obesity or Overweight Trial completed
- Minor: Eloralintide (LY3841136) in Healthy Participants Trial completed
- Minor: Eloralintide (LY3841136) · Obesity or Overweight Enrollment closed, study ongoing
- Minor: Gene Therapy Drug · Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis Enrollment closed, study ongoing
- Minor: SL-325 in Healthy Volunteers Trial completed
- Minor: Migaldendranib in Healthy Volunteers Trial completed
- Minor: Eloralintide (LY3841136) · Renal Impairment and in Participants With Normal Renal Function Trial completed
- Minor: Real-World Study of a Calcium Sodium Phosphosilicate Anti-Sensitivity Toothpaste for Dentin Hypersensitivity Relief Trial completed
- Minor: DOT Spectacles in Chinese Children Extension Enrollment closed, study ongoing
- Minor: Collection of Blood Samples for New Diagnostic Devices 2 Trial completed
- Minor: Korean Post-marketing Surveillance for Xeljanz XR Trial completed
- Minor: Activia Kefir Consumption in Real-world Setting Enrollment closed, study ongoing
- Minor: Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing Enrollment closed, study ongoing
- Minor: Specific Gait Patterns · Multiple Sclerosis Trial completed
- Minor: Etrasimod · Moderate to Severe Ulcerative Colitis Enrollment closed, study ongoing
- Minor: Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease Trial completed
- Minor: Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea Enrollment closed, study ongoing
- Minor: Iovera®° System · Upper Extremity Spasticity Trial completed
- Minor: SPN-812 (Viloxazine Extended-release Capsule) Primary and study completion pushed from Sep 2026 to Dec 2026
- Minor: Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy Enrollment closed, study ongoing
- Minor: AZA+Lus VS AZA Monotherapy in HR-MDS Completed without a posted recruiting period
- Minor: Recurrent Breast Cancer and Repeated Radiation Therapy Enrollment closed, study ongoing
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates